Blood pressure pill tested to boost cancer drug power
NCT ID NCT05387512
Summary
This study tested if adding a common blood pressure medication (a beta-blocker) to a standard immunotherapy drug (camrelizumab) works better for controlling advanced non-small cell lung cancer. Researchers compared the two-drug combination against the immunotherapy drug alone in 59 patients. They also analyzed whether the potential benefits would be worth the cost for the healthcare system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Pharmacy, Affiliated Hospital of Nantong University
Nantong, Jiangsu, 226000, China
Conditions
Explore the condition pages connected to this study.